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Background - Current data regarding risk factors for heart failure (HF) events are limited mostly to the occurrence of a first event. The present 
study was designed to identify risk factors for recurrent HF events in the MADIT-II population.
Methods - The Prentice, Williams, and Peterson (PWP) statistical model was utilized to identify and compare the risk factors for a first and second 
HF hospitalization among 1218 patients enrolled in the MADIT-II trial.
Results - Risk factors for a first HF hospitalization included treatment with an ICD, NYHA class > 2, female sex, atrial fibrillation, prolonged QRS, 
increased heart rate, and the presence of pre-renal azotemia (defined as a BUN to creatinine ratio > 20 [Table]). In contrast, after the occurrence 
of a first HF event, the risk associated with most covariates was attenuated, and only pre-renal azotemia independently predicted the risk of 
subsequent HF hospitalizations (Table). Patients who experienced a second HF hospitalization in the trial had a 6.73-fold (p-value < 0.001) increase 
in the risk of subsequent mortality.
Conclusions - Among identified HF risk factors, an increased BUN to creatinine ratio is a major predictor of recurrent HF events. These findings 
should direct more focus to the prevention of HF progression among patients with evidence of pre-renal azotemia.
Table: Risk factors for first and second HF hospitalizations in MADIT-II patients 
End Point
First HF event Second HF event
Risk Factor Adjusted hazard ratio P-value Adjusted hazard ratio P-value
ICD vs. non- ICD 1.31 0.05 1.25 0.34
NYHA > II * 1.95 < 0.001 0.91 0.58
Female 1.38 0.04 1.13 0.59
Atrial fibrillation * 1.90 0.001 0.92 0.74
QRS > 120 msec 1.41 0.01 1.16 0.40
Heart rate >= 80 bpm 1.35 0.03 1.02 0.93
BUN:creatinine > 20 1.45 0.01 1.52 0.02
*P-value for interaction between the 2 end points < 0.05
